De novo clonal expansion of pathogen-specific effector CD8+ T cells in response to sepsis-inducing pathogens and resultant inflammation leads to the potential for a preponderance of actively responding effector cells — especially early in the septic timeline. This evidence concerns the gene CD8A and Sepsis.